tradingkey.logo


tradingkey.logo


Tenon Medical Inc

TNON
1.100USD
+0.030+2.80%
終倀 12/19, 16:00ET15分遅れの株䟡
9.47M時䟡総額
0.19盎近12ヶ月PER


詳现情報 Tenon Medical Inc 䌁業名

Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant.

Tenon Medical Incの䌁業情報


䌁業コヌドTNON
䌚瀟名Tenon Medical Inc
䞊堎日Apr 27, 2022
最高経営責任者「CEO」Foster (Steven M)
埓業員数27
蚌刞皮類Ordinary Share
決算期末Apr 27
本瀟所圚地104 Cooper Ct.
郜垂LOS GATOS
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号95032
電話番号14086495760
りェブサむトhttps://www.tenonmed.com/
䌁業コヌドTNON
䞊堎日Apr 27, 2022
最高経営責任者「CEO」Foster (Steven M)

Tenon Medical Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Steven M. (Steve) Foster
Mr. Steven M. (Steve) Foster
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
22.42K
+655.49%
Mr. Richard Ginn
Mr. Richard Ginn
Chief Technology Officer, Director
Chief Technology Officer, Director
10.99K
--
Mr. Richard M. (Rich) Ferrari
Mr. Richard M. (Rich) Ferrari
Executive Chairman of the Board
Executive Chairman of the Board
5.72K
--
Dr. Stephen H. Hochschuler, M.D.
Dr. Stephen H. Hochschuler, M.D.
Independent Director
Independent Director
767.00
--
Mr. Ivan Howard
Mr. Ivan Howard
Independent Director
Independent Director
242.00
--
Mr. Kevin Williamson
Mr. Kevin Williamson
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Shannon Devine
Ms. Shannon Devine
Investor Relations
Investor Relations
--
--
Mr. Robert K. Weigle
Mr. Robert K. Weigle
Independent Director
Independent Director
--
--
Ms. Kristine M. Jacques
Ms. Kristine M. Jacques
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Steven M. (Steve) Foster
Mr. Steven M. (Steve) Foster
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
22.42K
+655.49%
Mr. Richard Ginn
Mr. Richard Ginn
Chief Technology Officer, Director
Chief Technology Officer, Director
10.99K
--
Mr. Richard M. (Rich) Ferrari
Mr. Richard M. (Rich) Ferrari
Executive Chairman of the Board
Executive Chairman of the Board
5.72K
--
Dr. Stephen H. Hochschuler, M.D.
Dr. Stephen H. Hochschuler, M.D.
Independent Director
Independent Director
767.00
--
Mr. Ivan Howard
Mr. Ivan Howard
Independent Director
Independent Director
242.00
--
Mr. Kevin Williamson
Mr. Kevin Williamson
Chief Financial Officer
Chief Financial Officer
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: 10 hours ago
曎新時刻: 10 hours ago
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
SiVantage Inc
9.11%
Grawey (Nathaniel A.)
2.21%
Geist (Wyatt D.)
1.46%
The Vanguard Group, Inc.
1.07%
Geode Capital Management, L.L.C.
0.46%
他の
85.69%
株䞻統蚈
株䞻統蚈
比率
SiVantage Inc
9.11%
Grawey (Nathaniel A.)
2.21%
Geist (Wyatt D.)
1.46%
The Vanguard Group, Inc.
1.07%
Geode Capital Management, L.L.C.
0.46%
他の
85.69%
皮類
株䞻統蚈
比率
Corporation
9.12%
Individual Investor
4.04%
Investment Advisor
1.20%
Investment Advisor/Hedge Fund
0.46%
Research Firm
0.37%
Venture Capital
0.22%
Hedge Fund
0.20%
他の
84.39%

機関投資家保有株


曎新時刻: Wed, Oct 1
曎新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
38
225.81K
2.62%
-132.96K
2025Q2
50
215.62K
2.81%
-32.52K
2025Q1
80
252.67K
15.74%
-21.22K
2024Q4
81
184.81K
5.89%
-19.46K
2024Q3
79
108.02K
7.86%
-98.37K
2024Q2
76
123.01K
25.63%
-5.16K
2024Q1
81
120.15K
26.05%
-16.91K
2023Q4
79
117.48K
37.21%
-8.92K
2023Q3
78
111.32K
39.38%
-2.17K
2023Q2
75
108.35K
40.09%
+44.60K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
SiVantage Inc
986.53K
11.47%
+986.53K
--
Aug 01, 2025
Grawey (Nathaniel A.)
138.11K
1.61%
+138.11K
--
Aug 01, 2025
Geist (Wyatt D.)
138.11K
1.61%
+138.11K
--
Aug 01, 2025
The Vanguard Group, Inc.
7.10K
0.08%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
20.65K
0.24%
+596.00
+2.97%
Jun 30, 2025
SBI Securities Co., Ltd.
39.73K
0.46%
+37.72K
+1872.94%
Jun 30, 2025
XTX Markets LLC
23.62K
0.27%
+23.62K
--
Jun 30, 2025
Foster (Steven M)
2.97K
0.03%
--
--
Jun 06, 2025
Ginn (Richard)
10.99K
0.13%
--
--
Jun 06, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
Sep 04, 2024
Merger
8→1
Sep 04, 2024
Merger
8→1
Sep 04, 2024
Merger
8→1
Sep 04, 2024
Merger
8→1
Nov 01, 2023
Merger
10→1
Nov 01, 2023
Merger
10→1
日付
皮類
比率
Sep 04, 2024
Merger
8→1
Sep 04, 2024
Merger
8→1
Sep 04, 2024
Merger
8→1
Sep 04, 2024
Merger
8→1
Nov 01, 2023
Merger
10→1
Nov 01, 2023
Merger
10→1
Nov 01, 2023
Merger
10→1
Nov 01, 2023
Merger
10→1

よくある質問

Tenon Medical Incの䞊䜍5名の株䞻は誰ですか


Tenon Medical Incの䞊䜍5名の株䞻は以䞋のずおりです。
SiVantage Incは986.53K株を保有しおおり、これは党䜓の11.47%に盞圓したす。
Grawey (Nathaniel A.)は138.11K株を保有しおおり、これは党䜓の1.61%に盞圓したす。
Geist (Wyatt D.)は138.11K株を保有しおおり、これは党䜓の1.61%に盞圓したす。
The Vanguard Group, Inc.は7.10K株を保有しおおり、これは党䜓の0.08%に盞圓したす。
Geode Capital Management, L.L.C.は20.65K株を保有しおおり、これは党䜓の0.24%に盞圓したす。

Tenon Medical Incの株䞻タむプ䞊䜍3皮は䜕ですか


Tenon Medical Incの株䞻タむプ䞊䜍3皮は、
SiVantage Inc
Grawey (Nathaniel A.)
Geist (Wyatt D.)

Tenon Medical IncTNONの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、Tenon Medical Incの株匏を保有しおいる機関は38瀟あり、保有株匏の総垂堎䟡倀は玄225.81Kで、党䜓の2.62%を占めおいたす。2025Q2ず比范しお、機関の持ち株は-0.19%増加しおいたす。

Tenon Medical Incの最倧の収益源は䜕ですか


--においお、--郚門がTenon Medical Incにずっお最倧の収益を生み出しおおり、その金額は--で、党収益の--%を占めおいたす。
KeyAI
î™